Medical Devices Startups

ICON plc is a global Contract Research Organization providing consulting and outsourced development services to pharmaceutical, biotechnology, medical device, and government organizations to accelerate drug and device development. The company supports clients across all phases of clinical development with integrated services spanning study design, patient recruitment, digital trial solutions, and commercialization.

1 investor

ICU Vision Care develops digital therapeutics for pediatric strabismus (crossed eyes), with plans to pursue FDA approval and eventual myopia management capabilities. The company operates vision care centers and provides customized vision examinations by specialized optometrists.

1 investor

Identifeye provides a fundus imaging platform combining a portable camera device and cloud-based portal software for retinal screening in point-of-care settings. The system serves healthcare providers and clinics conducting diabetic retinopathy and other retinal disease screenings.

1 investor

iDose TR is a procedural pharmaceutical implant that delivers travoprost therapy to reduce intraocular pressure in patients with open-angle glaucoma or ocular hypertension. The implant uses a proprietary membrane with nanoporous material for controlled drug delivery as an alternative to daily eye drops.

1 investor

iECURE is a clinical-stage biotechnology company developing in vivo genome editing therapies that insert a functional copy of a gene into a patient's genome to treat rare, life-threatening genetic diseases in children. Its initial focus is on neurometabolic and urea cycle disorders, including ornithine transcarbamylase (OTC) deficiency.

1 investor

iFocus Health provides a data-driven digital health platform that helps patients and caregivers make informed treatment decisions for ADHD, combining AI, bioinformatics, and clinical expertise to improve treatment outcomes.

1 investor

IGS develops imaging and visualization technology based on inverse scattering theory to enable observation of previously invisible structures and phenomena. The company applies this core technology to solve problems in medical imaging, energy, infrastructure, and security sectors.

1 investor

Clinical Medical Services provides durable medical equipment, home health care, respiratory equipment, inhalation medications, home infusion services, and orthotics and prosthetics to patients across Puerto Rico through an integrated healthcare delivery system.

1 investor

Heuron develops medical AI software that analyzes brain CT and MRI images to aid physicians in diagnosing and triaging neurological conditions, including intracranial hemorrhage, large vessel occlusion, ischemic stroke, and Parkinson's disease. Its diagnostic-aid products (ICH, ELVO, ASPECTS, IPD) are intended for use by medical professionals in hospitals and stroke networks.

1 investor

IHH Healthcare is one of the world's largest private healthcare services providers, operating an integrated network of 89 hospitals across 10 countries. The company delivers hospital, primary care, and ancillary healthcare services under trusted brands including Acibadem, Mount Elizabeth, Gleneagles, and Fortis.

1 investor

Kidsmile (青苗儿童口腔) operates a chain of pediatric dental clinics across China, providing orthodontic and facial development management services for children. The company uses digital data and proprietary bite-guidance induction technology to prevent and treat malocclusion early.

1 investor

IKKO is developing a new medical imaging modality designed to be wearable, accurate, safe, and low-cost. The company operates in the medical imaging and health technology space.

1 investor

IKOMED Technologies develops medical devices to improve patient outcomes and clinical workflows for medical staff. The company combines deep expertise in medical device design, manufacturing, and commercialization with clinical leadership from cardiovascular surgery and interventional radiology.

1 investor

Iksuda develops antibody-drug conjugates (ADCs) with enhanced tumor specificity for treating difficult-to-treat cancers. The company designs class-leading ADC therapeutics incorporating novel payloads and platform technologies optimized for anti-cancer efficacy and patient safety.

1 investor

Spaya is an AI-powered retrosynthesis platform that identifies synthetic routes to target compounds by converting them into commercially available starting materials. It serves chemists and drug discovery teams seeking to accelerate research through rapid, customizable synthesis planning.

1 investor

iLabService provides infrastructure for regulated laboratories to capture, govern, and audit physical evidence from lab operations. The platform integrates environment monitoring, equipment utilization, inventory, samples, compliance, and audit trails into a single system serving labs requiring regulated operations and compliance management.

1 investor

Ilico Genetics develops a blood-based molecular test for the early detection of gastric cancer using methylated DNA markers, designed to identify disease years before traditional methods. The company serves gastroenterologists and patients in the oncology diagnostics space, with a platform technology applicable to precision medicine and disease prevention.

1 investor

Illumacell is a clinical-stage biotech company developing a non-invasive photodynamic therapy for cancer, combining its patented "Wall-of-Light" medical light device with the off-patent drug 5-ALA to destroy tumor cells at depth without surgery. It is pursuing Oral Potentially Malignant Disorders as a lead indication and is conducting early-stage clinical studies in Canada.

1 investor

Illuminare Bio develops Illuminare-1, a fluorescent imaging agent that makes peripheral nerves visible during surgery to help surgeons avoid nerve injury. The product is administered intravenously pre-operatively and works with standard surgical equipment across multiple procedure types including prostatectomy, mastectomy, hernia repair, and spinal surgery.

1 investor

illumiSonics develops MLI™, a proprietary molecular imaging platform that extracts diagnostic information from unstained tissue samples for use in pathology, surgical imaging, and ophthalmology. The technology enables virtual histology and AI-powered diagnostics without destructive sample consumption, targeting pharmaceutical companies, clinical labs, and surgical centers.

1 investor

Imagerie Cardinet operates medical imaging centers in France providing diagnostic imaging services including mammography and breast imaging, staffed by physicians and radiologists delivering comprehensive imaging expertise.

1 investor

Imaginab develops advanced imaging solutions for immuno-oncology that visualize immune cell activity and treatment response without invasive biopsies. The company serves oncologists and clinical researchers seeking non-invasive alternatives for patient monitoring and treatment decision-making.

1 investor

Imaginable Solutions makes Guided Hands, an assistive device that helps people with limited fine motor skills write, draw, paint, and use technology by translating shoulder movements into guided hand motions. It serves individuals with limited hand dexterity in the assistive/medical device category.

1 investor

Imaging Associates is a radiology practice in Australia providing diagnostic imaging services through clinics in Melbourne, Victoria, and Wagga Wagga, NSW, staffed by senior radiologists focused on patient care and using advanced medical imaging technology.

1 investor